KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Leases (2019 - 2026)

Boston Scientific's Leases history spans 8 years, with the latest figure at $547.0 million for Q1 2026.

  • On a quarterly basis, Leases rose 22.1% to $547.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $547.0 million, a 22.1% increase, with the full-year FY2025 number at $465.0 million, up 3.56% from a year prior.
  • Leases hit $547.0 million in Q1 2026 for Boston Scientific, up from $465.0 million in the prior quarter.
  • Over the last five years, Leases for BSX hit a ceiling of $547.0 million in Q1 2026 and a floor of $386.0 million in Q4 2022.
  • Historically, Leases has averaged $440.9 million across 5 years, with a median of $439.0 million in 2023.
  • Biggest five-year swings in Leases: decreased 11.26% in 2022 and later rose 22.1% in 2026.
  • Tracing BSX's Leases over 5 years: stood at $386.0 million in 2022, then increased by 13.73% to $439.0 million in 2023, then rose by 2.28% to $449.0 million in 2024, then increased by 3.56% to $465.0 million in 2025, then rose by 17.63% to $547.0 million in 2026.
  • Business Quant data shows Leases for BSX at $547.0 million in Q1 2026, $465.0 million in Q4 2025, and $495.0 million in Q3 2025.